Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Reserve your place

Conference Agenda

DAY 1: Tuesday 10th October 2017

Become The Choice Partner For Delivering Healthcare In Australia
08:30 - 09:00
Opening Panel discussion The new normal: Discover how the smartest companies are achieving access within a cash strapped economy
  • The future of the PBS, impact of the May budget and financial considerations on the healthcare industry
  • Do we only have two choices: to make better use of the money we have or to find more money?
  • The alternative to having more PBS funding
  • How to shape the business model of tomorrow to sustain the new normal

MSD Luke Cornish Senior Government Relations Manager MSD

Department of Health Penny Shakespeare First Assistant Secretary, Pharmaceutical Benefits Division Department of Health

Celgene Albert Spanos Head of Operations and Corporate Affairs Celgene

08:30 - 09:00
Access in the Asian pharma market and what it means to Australia
  • The key players in the Asian pharma market – China, Taiwan, Korea and Hong Kong
  • The reimbursement reality and how it varies by market The differences between access models and what Australia can learn from them

Alexion Pharmaceuticals Simon McErlane Regional Medical Director Alexion Pharmaceuticals

08:30 - 09:00
Primary Care Reform: the implications and opportunities for your company
  • Understand the drivers of change and model of care being targeted with these reforms
  • How the market will encourage innovation to shift the epicentre of care to the patient
  • Examine the impact of data collection and outcomes measurement on the patient management Greater opportunities for the generation of real world data

Sonic Clinical Services Dr Munro Neville Chief Medical Officer Sonic Clinical Services

08:30 - 09:00
Put the patient first. Uncovering pharma's value through the patient experience
  • What do patients really want and need?
  • Understanding the patient ecosystem including carers and loved ones
  • The key elements of a patient support program
  • How can pharma tangibly improve the patient experience?

Novartis Glenn Montgomery Director, Patient Access and Healthcare Systems Novartis

Alexion Pharmaceuticals Simon McErlane Regional Medical Director Alexion Pharmaceuticals

08:30 - 09:00
Put the patient first. Uncovering pharma’s value through the patient experience
  • What do patients really want and need?
  • Understanding the patient ecosystem including carers and loved ones
  • The key elements of a patient support program How can pharma tangibly improve the patient experience?

Novartis Glenn Montgomery Director, Patient Access and Healthcare Systems Novartis

Novartis Simon Fisher Chief Scientific Officer Novartis

08:30 - 09:00
Panel discussion Create patient centric solutions. The increasing importance of patient advocacy organisations and the patient voice.
  • The critical nature of patient centricity for delivering value in the Australian Healthcare sector
  • The role of patient organisations in the current patient ecosystem
  • The elements of an ideal pharma-patient organisation relationship
  • Understand the support gaps and how can pharma step in to provide an improved patient centric experience

Novartis Glenn Montgomery Director, Patient Access and Healthcare Systems Novartis

Biogen Kylie Bromley Associate Director of Sales & Marketing Biogen

Epilepsy Action Australia Carol Ireland CEO & Managing Director Epilepsy Action Australia

MS Australia Deidre MacKechnie CEO MS Australia

08:30 - 09:00
Design & deploy a disease awareness campaign
  • The benefits of disease awareness campaigns and their roles in creating patient centric opportunities
  • The basic elements of an awareness campaign
  • Understand the negative effects of social stigma and the role of pharma in turning this around
  • Leveraging traditional media as well as digital channels
  • Working with key partners such as HCOs and/or media agencies

Galderma Jessica Danaher Brand Manager – ACNE and Rosacea Galderma

08:30 - 09:00
Panel discussion How to respond more effectively to our changing customers’ needs.
  • Understanding the pressures which are changing our customers’ behaviour
  • Recognise the pharma value-add and how to deliver it
  • Identify more innovative (and effective) means of communication
  • Altering our day to day activities need to better service our audience

iNova Pharma Roberto Castro Commercial Operations Manager iNova Pharma

AbbVie Alida Rossi Customer Excellence Director AbbVie


Further speakers to be revealed

08:30 - 09:00
The alternative to coverage and frequency: Adding value to customers today
  • Uncover the value-add that customers are craving
  • Align sales targets (and incentives) to customers’ needs
  • The difference between outcomes vs inputs and deliverables
  • Potential models (from other industries/international pharma)
  • The impact of alternatives on staff morale and employee retention

Novartis Group Paul White National Sales Manager, Oncology Novartis Group

08:30 - 09:00
How to become the go-to source for healthcare content and increase engagement
  • The importance of credible content and reliable content sources for consumers and physicians
  • Why scientific data is the gateway to good engagement – and how you can use digital techniques to enhance communications
  • The benefits of enhanced content: how to measure ROI and plan for your success

Wiley Julia Ballard Senior Journal Publishing Manager Wiley

08:30 - 09:00
Fireside chat with Medicines Australia

This is an opportunity for you to have a conversation with Medicines Australia around policy, the Code of Conduct, general priorities, how they work with government and to understand how you are influencing the policy environment.

Medicines Australia Elizabeth de Somer Director Policy Medicines Australia

Further MA representatives to be confirmed

08:30 - 09:00
An update from the TGA's Product Regulation Group
  • The new expedited pathways for prescription medicines approval
  • The new orphan medicine eligibility criteria
  • TGA publication and transparency developments

Therapeutic Goods Administration Adrian Bootes Assistant Secretary, Prescription Medicines Authorisation Branch Therapeutic Goods Administration

DAY 2: Wednesday 11 October 2017

08:30 - 09:00
Updates from the Therapeutic Goods Administration
  • The new expedited pathways for prescription medicines approval
  • The new orphan medicine eligibility criteria
  • TGA publication and transparency developments

Therapeutic Goods Administration Adrian Bootes Assistant Secretary, Prescription Medicines Authorisation Branch Therapeutic Goods Administration

Leverage Innovation Opportunities
08:30 - 09:00
The medicine of the future is here now.

Which current advances in AI, Robotics, gene therapy, digital technologies, Virtual Reality and 3D Printing are entering our hospitals? A look at how they are going to shape the way we do business and interact with customers and patients.

MTPConnect Sue MacLeman CEO MTPConnect

Murdoch Childrens Research Institute James Dromey PhD Chief Operating Officer Murdoch Childrens Research Institute

Further speakers to be revealed

08:30 - 09:00
Take an agile approach to digital pharma – without breaking the bank
  • The underlying features of a nimble marketing team & how to cultivate them
  • Creating a content, service and lead generation tool
  • Developing patient centric apps for additional access
  • How to encourage an agile approach in the senior leadership team

Aspen Pharma Richard Clement Group Digital Marketing Manager Aspen Pharma

08:30 - 09:00
Fireside chat The changing pharma product landscape and its impact on your day to day activities. The end of blockbusters, the growth of niche products and their impact on day to day activities
  • Understand what the growth of biosimilars & niche products will mean for pharma companies
  • Have we reached the end of blockbusters?
  • The future product landscape in 5, 10, 20 years’ time
  • How the economics of personalised medicine could work and our responsibility to patients who are unable to afford the cost
  • The impact of smaller patient markets on profits and our management options

MSD Josie Downey Director, Oncology Business Unit MSD

Further speakers to be revealed

08:30 - 09:00
Create digital content that cuts through the noise
  • Create clear goals for your content strategy
  • The key traits of engaging and value-driven content
  • How to pick the right channels for the right audience
  • Beyond webinars – leveraging Facebook Live, Podcasts & video
  • The tools required to efficiently manage a cross team content strategy

Speaker to be revealed

08:30 - 09:00
Digital solutions for driving better health outcomes
  • How to forge relationships with consumers who are now the gatekeeper to their own healthcare
  • Case Study: Adjusting business processes to better align with patient/ practitioner behaviour and requirements
  • Methods to provide what patients and practitioners need through the latest in digital technology

Healthshare Chris Barakat Director of Business Development Healthshare

08:30 - 09:00
Foster an integrated approach to MSLs & medical teams
  • The value proposition of the MSL in the context of the field reps, KAM teams and marketing functions
  • How to define an MSL from a customer perspective (and avoid any confusion)
  • Allocate effective KPIs for the commercial and medical team Create the sales force of future: Identify your ideal ratio of commercial vs medical members

Further speakers to be revealed

08:30 - 09:00
Employee engagement: Balancing trust, motivation and measurement for a more productive workforce
  • Leverage the role of commercial excellence in supporting the sales and marketing functions
  • How can your firm attract and retain the best talent?
  • The key capabilities that we need to be developing to sustain future needs How to create a supportive and team focused culture

Mundipharma Damian Byers Director of Human Resources Mundipharma

08:30 - 09:00
Panel discussion Analysing the commercial team of the future.

With the growth of medical teams, non-existent blockbusters, the decrease in field force, development of niche products and restricted PBS funding, the question around relevance is one which we need to ask.

  • The business case for and against having a commercial team
  • How to respond to the changing needs of our customer and patients through a more flexible business structure
  • The growth of MSLs and their impact on marketing & sales teams
  • Analysing potential team scenarios in 5, 10 or 20 years time
  • Understand the factors which will impact on the structure of commercial teams

Takeda Pharmaceuticals Ben Hopkins Commercial Director Takeda Pharmaceuticals

Sanofi Tammy Lindrum Head of Sales and Key Account Management Sanofi

Johnson & Johnson Helen Perkins Director of Human Resources, ANZ Johnson & Johnson

UCB Shaun Holmgreen Head - Operational Excellence UCB

08:30 - 09:00
eyeforpharma key note panel discussion A future plan that works for both pharma and customers – is it possible?
  • To ensure the future performance of Australian pharma companies while customers are becoming more complex, how do we need to make more strategic collaboration and work together?
  • Where do we need to create change to build a long-term commercial business model?
  • How do leaders think our workforce will be different five years from now? How do you properly balance investments in new technology and new people/talent at the same time?

Novartis Oncology Lauren Carey General Manager Novartis Oncology

Further speakers to be revealed

DAY 1: Tuesday 10th October 2017

Become The Choice Partner For Delivering Healthcare In Australia
08:30 - 09:00
Opening Panel discussion The new normal: Discover how the smartest companies are achieving access within a cash strapped economy
  • The future of the PBS, impact of the May budget and financial considerations on the healthcare industry
  • Do we only have two choices: to make better use of the money we have or to find more money?
  • The alternative to having more PBS funding
  • How to shape the business model of tomorrow to sustain the new normal

MSD Luke Cornish Senior Government Relations Manager MSD

Department of Health Penny Shakespeare First Assistant Secretary, Pharmaceutical Benefits Division Department of Health

Celgene Albert Spanos Head of Operations and Corporate Affairs Celgene

08:30 - 09:00
Access in the Asian pharma market and what it means to Australia
  • The key players in the Asian pharma market – China, Taiwan, Korea and Hong Kong
  • The reimbursement reality and how it varies by market The differences between access models and what Australia can learn from them

Alexion Pharmaceuticals Simon McErlane Regional Medical Director Alexion Pharmaceuticals

08:30 - 09:00
Primary Care Reform: the implications and opportunities for your company
  • Understand the drivers of change and model of care being targeted with these reforms
  • How the market will encourage innovation to shift the epicentre of care to the patient
  • Examine the impact of data collection and outcomes measurement on the patient management Greater opportunities for the generation of real world data

Sonic Clinical Services Dr Munro Neville Chief Medical Officer Sonic Clinical Services

08:30 - 09:00
Put the patient first. Uncovering pharma's value through the patient experience
  • What do patients really want and need?
  • Understanding the patient ecosystem including carers and loved ones
  • The key elements of a patient support program
  • How can pharma tangibly improve the patient experience?

Novartis Glenn Montgomery Director, Patient Access and Healthcare Systems Novartis

Alexion Pharmaceuticals Simon McErlane Regional Medical Director Alexion Pharmaceuticals

08:30 - 09:00
Put the patient first. Uncovering pharma’s value through the patient experience
  • What do patients really want and need?
  • Understanding the patient ecosystem including carers and loved ones
  • The key elements of a patient support program How can pharma tangibly improve the patient experience?

Novartis Glenn Montgomery Director, Patient Access and Healthcare Systems Novartis

Novartis Simon Fisher Chief Scientific Officer Novartis

08:30 - 09:00
Panel discussion Create patient centric solutions. The increasing importance of patient advocacy organisations and the patient voice.
  • The critical nature of patient centricity for delivering value in the Australian Healthcare sector
  • The role of patient organisations in the current patient ecosystem
  • The elements of an ideal pharma-patient organisation relationship
  • Understand the support gaps and how can pharma step in to provide an improved patient centric experience

Novartis Glenn Montgomery Director, Patient Access and Healthcare Systems Novartis

Biogen Kylie Bromley Associate Director of Sales & Marketing Biogen

Epilepsy Action Australia Carol Ireland CEO & Managing Director Epilepsy Action Australia

MS Australia Deidre MacKechnie CEO MS Australia

08:30 - 09:00
Design & deploy a disease awareness campaign
  • The benefits of disease awareness campaigns and their roles in creating patient centric opportunities
  • The basic elements of an awareness campaign
  • Understand the negative effects of social stigma and the role of pharma in turning this around
  • Leveraging traditional media as well as digital channels
  • Working with key partners such as HCOs and/or media agencies

Galderma Jessica Danaher Brand Manager – ACNE and Rosacea Galderma

08:30 - 09:00
Panel discussion How to respond more effectively to our changing customers’ needs.
  • Understanding the pressures which are changing our customers’ behaviour
  • Recognise the pharma value-add and how to deliver it
  • Identify more innovative (and effective) means of communication
  • Altering our day to day activities need to better service our audience

iNova Pharma Roberto Castro Commercial Operations Manager iNova Pharma

AbbVie Alida Rossi Customer Excellence Director AbbVie


Further speakers to be revealed

08:30 - 09:00
The alternative to coverage and frequency: Adding value to customers today
  • Uncover the value-add that customers are craving
  • Align sales targets (and incentives) to customers’ needs
  • The difference between outcomes vs inputs and deliverables
  • Potential models (from other industries/international pharma)
  • The impact of alternatives on staff morale and employee retention

Novartis Group Paul White National Sales Manager, Oncology Novartis Group

08:30 - 09:00
How to become the go-to source for healthcare content and increase engagement
  • The importance of credible content and reliable content sources for consumers and physicians
  • Why scientific data is the gateway to good engagement – and how you can use digital techniques to enhance communications
  • The benefits of enhanced content: how to measure ROI and plan for your success

Wiley Julia Ballard Senior Journal Publishing Manager Wiley

08:30 - 09:00
Fireside chat with Medicines Australia

This is an opportunity for you to have a conversation with Medicines Australia around policy, the Code of Conduct, general priorities, how they work with government and to understand how you are influencing the policy environment.

Medicines Australia Elizabeth de Somer Director Policy Medicines Australia

Further MA representatives to be confirmed

08:30 - 09:00
An update from the TGA's Product Regulation Group
  • The new expedited pathways for prescription medicines approval
  • The new orphan medicine eligibility criteria
  • TGA publication and transparency developments

Therapeutic Goods Administration Adrian Bootes Assistant Secretary, Prescription Medicines Authorisation Branch Therapeutic Goods Administration

Register Now

Save AU $300 with our Super Early Bird discount. Expires Today!

DAY 2: Wednesday 11 October 2017

08:30 - 09:00
Updates from the Therapeutic Goods Administration
  • The new expedited pathways for prescription medicines approval
  • The new orphan medicine eligibility criteria
  • TGA publication and transparency developments

Therapeutic Goods Administration Adrian Bootes Assistant Secretary, Prescription Medicines Authorisation Branch Therapeutic Goods Administration

Leverage Innovation Opportunities
08:30 - 09:00
The medicine of the future is here now.

Which current advances in AI, Robotics, gene therapy, digital technologies, Virtual Reality and 3D Printing are entering our hospitals? A look at how they are going to shape the way we do business and interact with customers and patients.

MTPConnect Sue MacLeman CEO MTPConnect

Murdoch Childrens Research Institute James Dromey PhD Chief Operating Officer Murdoch Childrens Research Institute

Further speakers to be revealed

08:30 - 09:00
Take an agile approach to digital pharma – without breaking the bank
  • The underlying features of a nimble marketing team & how to cultivate them
  • Creating a content, service and lead generation tool
  • Developing patient centric apps for additional access
  • How to encourage an agile approach in the senior leadership team

Aspen Pharma Richard Clement Group Digital Marketing Manager Aspen Pharma

08:30 - 09:00
Fireside chat The changing pharma product landscape and its impact on your day to day activities. The end of blockbusters, the growth of niche products and their impact on day to day activities
  • Understand what the growth of biosimilars & niche products will mean for pharma companies
  • Have we reached the end of blockbusters?
  • The future product landscape in 5, 10, 20 years’ time
  • How the economics of personalised medicine could work and our responsibility to patients who are unable to afford the cost
  • The impact of smaller patient markets on profits and our management options

MSD Josie Downey Director, Oncology Business Unit MSD

Further speakers to be revealed

08:30 - 09:00
Create digital content that cuts through the noise
  • Create clear goals for your content strategy
  • The key traits of engaging and value-driven content
  • How to pick the right channels for the right audience
  • Beyond webinars – leveraging Facebook Live, Podcasts & video
  • The tools required to efficiently manage a cross team content strategy

Speaker to be revealed

08:30 - 09:00
Digital solutions for driving better health outcomes
  • How to forge relationships with consumers who are now the gatekeeper to their own healthcare
  • Case Study: Adjusting business processes to better align with patient/ practitioner behaviour and requirements
  • Methods to provide what patients and practitioners need through the latest in digital technology

Healthshare Chris Barakat Director of Business Development Healthshare

08:30 - 09:00
Foster an integrated approach to MSLs & medical teams
  • The value proposition of the MSL in the context of the field reps, KAM teams and marketing functions
  • How to define an MSL from a customer perspective (and avoid any confusion)
  • Allocate effective KPIs for the commercial and medical team Create the sales force of future: Identify your ideal ratio of commercial vs medical members

Further speakers to be revealed

08:30 - 09:00
Employee engagement: Balancing trust, motivation and measurement for a more productive workforce
  • Leverage the role of commercial excellence in supporting the sales and marketing functions
  • How can your firm attract and retain the best talent?
  • The key capabilities that we need to be developing to sustain future needs How to create a supportive and team focused culture

Mundipharma Damian Byers Director of Human Resources Mundipharma

08:30 - 09:00
Panel discussion Analysing the commercial team of the future.

With the growth of medical teams, non-existent blockbusters, the decrease in field force, development of niche products and restricted PBS funding, the question around relevance is one which we need to ask.

  • The business case for and against having a commercial team
  • How to respond to the changing needs of our customer and patients through a more flexible business structure
  • The growth of MSLs and their impact on marketing & sales teams
  • Analysing potential team scenarios in 5, 10 or 20 years time
  • Understand the factors which will impact on the structure of commercial teams

Takeda Pharmaceuticals Ben Hopkins Commercial Director Takeda Pharmaceuticals

Sanofi Tammy Lindrum Head of Sales and Key Account Management Sanofi

Johnson & Johnson Helen Perkins Director of Human Resources, ANZ Johnson & Johnson

UCB Shaun Holmgreen Head - Operational Excellence UCB

08:30 - 09:00
eyeforpharma key note panel discussion A future plan that works for both pharma and customers – is it possible?
  • To ensure the future performance of Australian pharma companies while customers are becoming more complex, how do we need to make more strategic collaboration and work together?
  • Where do we need to create change to build a long-term commercial business model?
  • How do leaders think our workforce will be different five years from now? How do you properly balance investments in new technology and new people/talent at the same time?

Novartis Oncology Lauren Carey General Manager Novartis Oncology

Further speakers to be revealed

Don't miss out - register now

Discount ends TODAY! Save AU $300 with our Super Early Bird discount. Don't miss out!